Ramesh Pokhriyal launches affordable DuroKea Series developed by IIT Hyderabad to fight COVID-19

Union minister of education Ramesh Pokhriyal ‘Nishank’ on 16 April virtually launched the world’s first affordable antimicrobial technology DuroKea Series, developed by IIT Hyderabad researchers, to fight COVID-19.

By Newsmeter Network  Published on  16 April 2021 11:31 AM GMT
Ramesh Pokhriyal launches affordable DuroKea Series developed by IIT Hyderabad to fight COVID-19

Hyderabad: Union minister of education Ramesh Pokhriyal 'Nishank' on 16 April virtually launched the world's first affordable antimicrobial technology DuroKea Series, developed by IIT Hyderabad researchers, to fight COVID-19.

The researcher from the Indian Institute of Technology Hyderabad (IITH) led by Dr. Jyotsnendu Giri, associate professor in biomedical engineering and founder of EaffoCare Innovation Pvt. Ltd. incubating at iTIC, IIT Hyderabad, developed DuroKea long-lasting technologies to combat the spread of the COVID-19 virus.

This next-generation DuroKea antimicrobial technology starts at Rs. 189, kills 99.99 per cent germs instantly and leaves behind a protective nanoscale coating that lasts up to 35 days till the next wash.

The minister said the unique property of DuroKea is to ensure instant killing (within 60 seconds) and prolonged protection which is an immense necessity during the current situation. This revolutionary antimicrobial property has been tested and certified by the Central government accredited lab and field-tested at the IIT Hyderabad campus, he added.

Congratulating the Durokea team, the director of IIT Hyderabad, Prof. B.S Murty highlighted the many inventions to come out of IITH during the pandemic, including low-cost ventilators, effective masks, mobile apps and fast COVID-19 test-kit. "Durokea is one such unique invention to come out of IIT Hyderabad to fight against COVID-19," he said.

Products in the Durokea Serious instantly kill germs and provide prolonged protection against a wide range of germs, including COVID-19 virus. Each product has been extensively tested through field trial and validated in different Central-accredited laboratories.

Next Story
Share it